Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jul 2;10(7):a028571.
doi: 10.1101/cshperspect.a028571.

Negative Regulation of Cytokine Signaling in Immunity

Affiliations
Review

Negative Regulation of Cytokine Signaling in Immunity

Akihiko Yoshimura et al. Cold Spring Harb Perspect Biol. .

Abstract

Cytokines are key modulators of immunity. Most cytokines use the Janus kinase and signal transducers and activators of transcription (JAK-STAT) pathway to promote gene transcriptional regulation, but their signals must be attenuated by multiple mechanisms. These include the suppressors of cytokine signaling (SOCS) family of proteins, which represent a main negative regulation mechanism for the JAK-STAT pathway. Cytokine-inducible Src homology 2 (SH2)-containing protein (CIS), SOCS1, and SOCS3 proteins regulate cytokine signals that control the polarization of CD4+ T cells and the maturation of CD8+ T cells. SOCS proteins also regulate innate immune cells and are involved in tumorigenesis. This review summarizes recent progress on CIS, SOCS1, and SOCS3 in T cells and tumor immunity.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The cytokine signaling and their major negative regulators. There are four types of cytokine receptors: (1) receptors that activate nuclear factor (NF)-κB and mitogen-activated protein (MAP) kinases; (2) receptors that activate the Janus kinase and signal transducers and activators of transcription (JAK-STAT) pathway; (3) transforming growth factor (TGF)-β receptors; and (4) growth factor receptor family. Typical negative regulators are also shown. TNF, Tumor necrosis factor; TNFR, TNF receptor; FGF, fibroblast growth factor; FGFR, FGF receptor; IKK, IκB kinase; SOCS/CIS, suppressor of cytokine signaling/cytokine-inducible Src homology 2 (SH2)-containing protein; Spred, Sprouty-related protein with an EVH1 domain.
Figure 2.
Figure 2.
Structure and function of the suppressor of cytokine signaling (SOCS) family. The SOCS family consists of eight family members. All eight members share a central Src homology 2 (SH2) domain and a carboxy-terminal SOCS box. In addition, SOCS1 and SOCS3 possess a kinase inhibitory region (KIR) that inhibits Janus kinase (JAK) activity. (Right) The general mechanism of the action of cytokine-inducible SH2-containing protein (CIS), SOCS1, and SOCS3. STAT, Signal transducers and activators of transcription; JAB, Janus kinase-binding protein.
Figure 3.
Figure 3.
Structure of the complex of Janus kinase (JAK)2 and suppressor of cytokine signaling (SOCS)3, and gp130 phosphopeptide. SOCS3 binds the kinase domains of JAK1, JAK2, and TYK2 and inhibits its catalytic activity by blocking the substrate-binding site with its kinase inhibitory region. SOCS3 remains bound to gp130 while in complex with JAK (beige) and adenosine triphosphate (ATP) binding is unaffected. (Based on Kershaw et al. 2013, with permission, from the authors.)

References

    1. Ahmed CM, Larkin J IIII, Johnson HM. 2015. SOCS1 mimetics and antagonists: A complementary approach to positive and negative regulation of immune function. Front Immunol 6: 183. - PMC - PubMed
    1. Al Muftah WA, Al-Shafai M, Zaghlool SB, Visconti A, Tsai PC, Kumar P, Spector T, Bell J, Falchi M, Suhre K. 2016. Epigenetic associations of type 2 diabetes and BMI in an Arab population. Clin Epigenetics 8: 13. - PMC - PubMed
    1. Aman MJ, Migone TS, Sasaki A, Ascherman DP, Zhu M, Soldaini E, Imada K, Miyajima A, Yoshimura A, Leonard WJ. 1999. CIS associates with the interleukin-2 receptor β chain and inhibits interleukin-2-dependent signaling. J Biol Chem 274: 30266–30272. - PubMed
    1. Asselbergs FW, Guo YR, van Iperen EPA, Sivapalaratnam S, Tragante V, Lanktree MB, Lange LA, Almoguera B, Appelman YE, Barnard J, et al. 2012. Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. Am J Hum Genet 91: 823–838. - PMC - PubMed
    1. Babon JJ, Kershaw NJ, Murphy JM, Varghese LN, Laktyushin A, Young SN, Lucet IS, Norton RS, Nicola NA. 2012. Suppression of cytokine signaling by SOCS3: Characterization of the mode of inhibition and the basis of its specificity. Immunity 36: 239–250. - PMC - PubMed

Publication types